Financhill
Back

Pyxis Oncology Quote, Financials, Valuation and Earnings

Pyxis Oncology Price Quote

$4.37
-0.04 (-0.91%)
(Updated: May 3, 2024 at 4:00 PM ET)

Pyxis Oncology Key Stats

Sell
30
Pyxis Oncology (PYXS) is a Sell

Day range:
$4.31 - $4.48
52-week range:
$1.35 - $6.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.04%

Volume:
188.1K
Avg. volume:
694.1K
1-year change:
58.63%
Market cap:
$256.4M
Revenue:
$0
EPS:
$-1.84

How Much Does Pyxis Oncology Make?

Data Unavailable

Is Pyxis Oncology Growing As A Company?

Data Unavailable

Pyxis Oncology Stock Price Performance

  • Did Pyxis Oncology Stock Go Up Last Month?
    Pyxis Oncology share price went down by -18.03% last month
  • Did PYXS's Share Price Rise Over The Last Year?
    PYXS share price rose by 58.63% over the past 1 year

What Is Pyxis Oncology 52-Week High & Low?

Pyxis Oncology Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Pyxis Oncology?

  • How Much Debt Does Pyxis Oncology Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Pyxis Oncology Have?
    Cash and short term investments quarterly total is $119.3M
  • What Is Pyxis Oncology’s Book Value Per Share?
    Book value per share is 2.81

Is Pyxis Oncology Cash Flow Positive?

  • What Is PYXS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$70.7M
  • What Is Pyxis Oncology’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $5.9M
  • What Is Pyxis Oncology’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$104.8M

Pyxis Oncology Return On Invested Capital

Data Unavailable

Pyxis Oncology Earnings Date & Stock Price

Pyxis Oncology Competitors

  • Who Are Pyxis Oncology's Competitors?
    Below is a list of companies who compete with Pyxis Oncology or are related in some way:
    • Alpine Immune Sciences Inc (ALPN)
    • Apyx Medical Corp (APYX)
    • Nortech Systems Inc (NSYS)
    • Phio Pharmaceuticals Corp (PHIO)
    • X4 Pharmaceuticals Inc (XFOR)

Pyxis Oncology Dividend Yield

Data Unavailable

Pyxis Oncology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 30.53%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 7.33
Upside from Last Price: 66.29%

Major Shareholders

  • How many PYXS shares are owned by institutional investors?
    23.8M PYXS shares are owned by institutional investors
  • How many PYXS shares are owned by insiders?
    6M PYXS shares are owned by insiders